ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Zydus Lifesciences Ltd Complete list of announcements declared & dividend announcements by Zydus Lifesciences Ltd ZYDUSLIFE

Zydus Lifesciences Ltd ZYDUSLIFE listed on NSE and deals in

Announcements and dividends declared by Zydus Lifesciences Ltd ZYDUSLIFE

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 06, 2025, titled "Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg".
Announcement as on 07 October 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication
Announcement as on 06 October 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 06, 2025, titled "Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL".
Announcement as on 06 October 2025

Zydus Lifesciences gets USFDA nod for Deflazacort oral suspension
Zydus Lifesciences Ltd received final USFDA approval for its generic Deflazacort oral suspension (22.75 mg/ml) on Monday. This medication treats Duchenne Muscular Dystrophy (DMD) in patients aged five and older by decreasing inflammation. The company plans
Announcement as on 06 October 2025

IPA names Zydus Lifesciences MD Sharvil Patel as President
Sharvil Patel is the new president of the Indian Pharmaceutical Alliance. He takes over from Samir Mehta. Glenn Saldanha becomes the vice president. The IPA represents 23 national pharmaceutical companies. The new team will build on reforms and breakthroug
Announcement as on 03 October 2025

Announcements by Zydus Lifesciences Ltd first page | Next page | Prev page |

ZYDUSLIFE Zydus Lifesciences Ltd current price & indicator signals

Moving Averages for Zydus Lifesciences Ltd

  • 5Day Average: 879.81
  • 12Day Average: 882.42
  • 20Day Average: 894.51
  • 50Day Average: 897.92
  • 100Day Average: 910.17
  • 150Day Average: 941.34
  • 200Day Average: 949.36

ZYDUSLIFE Indicators & signals

Indicator MACD (12,26,9)

883.09, 892.32, -5.8
Indicator MACD is in negative zone

Indicator ADX (14)

38, 14.74, 32.82
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ZYDUSLIFE Zydus Lifesciences Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Apr 2026 864.25 835.50 to 866.00 0.12% 1.57 times
01 Wed Apr 2026 863.20 857.10 to 900.00 -0.92% 1.19 times
30 Mon Mar 2026 871.20 869.10 to 892.20 -2.84% 1.74 times
27 Fri Mar 2026 896.70 894.00 to 910.40 -0.77% 1.46 times
25 Wed Mar 2026 903.70 886.50 to 914.00 1.95% 0.89 times
24 Tue Mar 2026 886.40 865.10 to 888.90 3% 0.66 times
23 Mon Mar 2026 860.60 858.00 to 899.00 -3.36% 1.03 times
20 Fri Mar 2026 890.50 880.20 to 896.00 1.64% 0.66 times
19 Thu Mar 2026 876.15 874.00 to 894.80 -2.61% 0.57 times
18 Wed Mar 2026 899.60 889.00 to 905.95 1.1% 0.71 times
17 Tue Mar 2026 889.80 887.85 to 902.70 0.33% 1.1 times
16 Mon Mar 2026 886.90 877.10 to 911.90 -2.1% 1.13 times

Videos related to: ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

 

Back to top